Page 32 - Read Online
P. 32

Page 6 of 10                                                       Watanabe. Vessel Plus 2020;4:4  I  http://dx.doi.org/10.20517/2574-1209.2019.27
                        [61]
               generation . The risk factors of Alzheimer’s disease are known to be inflammation, lipid metabolism
               (Apoe), and atherosclerosis [61-63] . A clinical prospective study has shown that atherosclerosis in carotid
                                                              [64]
               arteries leads to the progression of Alzheimer’s disease . Osmotin protects against amyloid-β deposition,
               tau phosphorylation, and apoptotic neurodegeneration through AdipoR1 followed by the AMPK/
               sirtuin 1/sterol regulatory element-binding protein 2 pathway in neuronal cells [25,65-67] . It also enhances
                                                                                                 [68]
               neurite outgrowth and synaptic complexity via AdipoR1/nogo-66 receptor NgR1 signaling . These
               findings indicate that osmotin is a potential candidate for the treatment of neurological disorders such as
               Alzheimer’s disease. A preclinical trial study recently reported the usefulness of intravenous administration
               of osmotin-loaded magnetic nanoparticles in combination with electromagnetic guidance in the
                                           [69]
               treatment of Alzheimer’s disease . These effects of osmotin are compatible with neuroprotective effects of
               adiponectin and AdipoRon in Alzheimer’s disease [70-73] .


               ANTI-TUMORIGENESIS EFFECT
               Cancer and atherosclerosis have been classified as non-communicable diseases by differing in target
                   [74]
               cells . However, both diseases have principally identical mechanisms such as cell proliferation induced
                                                       [75]
               by inflammation and reactive oxygen species . Adiponectin induces anti-angiogenesis and anti-tumor
                                                                      [13]
               activity through AdipoR1 via caspase-mediated EC apoptosis . Actually, adiponectin and AdipoRon
               suppress the proliferation of a variety of human cancer cells [76-78] . Similarly, osmotin induces cell cycle
                                                                   [10]
                                     [33]
               arrest in the G0/G1 phase  and suppresses cell proliferation . These findings suggest the possibility that
               osmotin may suppress tumor growth. However, further studies are needed to clarify this hypothesis.

               THERAPEUTIC STRATEGY
                                                                                  [13]
               Osmotin is a natural plant protein that is ubiquitous in fruits and vegetables . Osmotin is also known
                                                                         [13]
               to be a phytochemical that is resistant to heat treatment (cooking) . Furthermore, the osmotin protein
                                                                                                       [13]
               is relatively stable and may maintain activity even through contact with the human digestive system .
               Therefore, this phytochemical could be administered by ingestion of fruits and vegetables containing a
               great amount of osmotin or by oral administration of osmotin and/or its analogs that consist of the amino
                                                  [10]
               acid residue including an active center . However, the best drug delivery system (DDS) for osmotin
               administration is considered to be enveloped in nanocapsules in order to avoid digestive degradation [10,69] .
               Moreover, continuing preclinical and clinical investigations with osmotin, in particular combined with a
                                                                                                   [10]
               nanocapsule system as carrier vehicles into atherosclerotic lesions, are essential for future studies . It is
               very important for DDS establishment to design the size of the nanocapsule so that it can go through a
               relatively wide gap between damaged vascular ECs, but not a normal gap between intact ECs in humans.
               The magnetic nanocapsule-based DDS with external electromagnetic guidance may be more useful
                                                          [69]
               to make osmotin cross endothelial gap junction . Future studies are needed to clarify whether oral
               administration of osmotin-loaded nanocapsules can treat vascular lesions in patients with atherosclerosis.
               Similarly, osmotin-like proteins derived from many vegetables and fruits are also regarded as adiponectin
               peptidomimetics and gather attention as novel therapeutic drug candidates for atherosclerosis and related
                      [79]
               diseases .

               CONCLUSION
               These findings indicate that the novel phytochemical osmotin might be an effective therapeutic agent for
               atherosclerosis, inflammation, neurodegeneration, and their related diseases and that AdipoR1 might be
               a crucial therapeutic target for these diseases. Osmotin may open up a new therapeutic window in the
               treatment of atherosclerosis in cases with hypoadiponectinemia and/or resistance against adiponectin and
               AdipoRon [10,30,80] . Osmotin also provides benefits to maintain vascular health and prevent vascular disease
               in healthy individuals.
   27   28   29   30   31   32   33   34   35   36   37